S

Shuang Ding

Chinese Academy of Sciences

ORCID: 0000-0002-9810-8428

Publishes on RNA modifications and cancer, Cancer-related molecular mechanisms research, SARS-CoV-2 and COVID-19 Research. 18 papers and 262 citations.

PubIndex Score61Top 39% · mid-careerHow it's scored

18Publications

262Total Citations

First publication: 2014First senior author: 2014

RNA modifications and cancer Cancer-related molecular mechanisms research SARS-CoV-2 and COVID-19 Research RNA Research and Splicing vaccines and immunoinformatics approaches

Top publicationsby citations

A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

Chang Yi Wang, Thomas P. Monath, Yu-Rou Lan et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2022

Cited by 76

Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses

Shuang Ding, Wuxiang Guan, Haibin Liu et al.|Cell Death and Disease|2024

Cited by 42

Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial

Pepijn Eijsvogel, Jean‐Cosme Dodart, Pinaki Misra et al.|Nature Medicine|2024

Cited by 38

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Shixia Wang, Farshad Guirakhoo, Chang Yi Wang et al.|Emerging Microbes & Infections|2022

Cited by 33

VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys

Madeline M. Vroom, Jean‐Cosme Dodart, Hanxin Lu et al.|Journal of Lipid Research|2024

Cited by 23